🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children

RecruitingNAAges 5 Years - 18 YearsAllAlexandria University
NCT07184203 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: • Tinea capitis patients with ages ranging from 5 to 18 year Exclusion Criteria: * Patients with contraindications to itraconazole * Patients with associated scalp disease. * Patients weighing less than 20 Kg.
💊

What it tests

  • Itraconazole (ITZ)
📍

Where

1 site
Faculty of Medicine
Alexandria, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy